Thousand Oaks’ Ceres sees stock price spike after patent approved
Ceres, a Thousand Oaks based agriculture-biotechnology company, saw shares spike 373 percent Wednesday after the company received a patent for its iCODE multi-gene trait development system. Ceres shares started the day at just 95 cents per share, and soared all the way to $4.80 when the markets opened at 6:30 a.m. PST. Ceres closed the Read More →
Read More →
Ceres plans to license corn-derived gene patent
Thousand Oaks-based energy crop firm Ceres has been granted a patent on a gene sequence derived from corn and plans to license the patent to big seed companies.
Read More →Ceres faces delisting from Nasdaq
Thousand Oaks-based energy crop company Ceres could be booted from the Nasdaq stock exchange if it doesn’t get its share price back above $1 in the next six months. Ceres said that it received a letter from the Nasdaq on April 28 notifying it that because its share price has lingered below $1 for 30 Read More →
Read More →Ceres to plow $23M raise into sorghum tests
Thousand Oaks-based energy crop firm Ceres has raised $23 million that it hopes will help it to break even as it continues testing its seeds in Brazil.
Read More →Ceres files for $20M offering
The Thousand Oaks-based firm said it would like to use the proceeds from the public offering to expand its Brazilian operations, participate in collaborations and break into new markets.
Read More →
Sponsored content:
2015-2016 Giving Guide
